Patrolling monocytes control tumor metastasis to the lung
Author(s) -
Richard N. Hanna,
Caglar Cekic,
Duygu Sag,
Robert Tacke,
Graham D. Thomas,
Heba Nowyhed,
Erica Herrley,
Nicole Rasquinha,
Sara McArdle,
Runpei Wu,
Esther Peluso,
Daniel Metzger,
Hiroshi Ichinose,
Iftach Shaked,
Grzegorz Chodaczek,
Subhra K. Biswas,
Catherine C. Hedrick
Publication year - 2015
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aac9407
Subject(s) - immunosurveillance , metastasis , cancer research , lung cancer , carcinogenesis , lung , immune system , immunotherapy , medicine , immunology , cancer , biology , pathology , tumor cells
The immune system plays an important role in regulating tumor growth and metastasis. Classical monocytes promote tumorigenesis and cancer metastasis, but how nonclassical "patrolling" monocytes (PMo) interact with tumors is unknown. Here we show that PMo are enriched in the microvasculature of the lung and reduce tumor metastasis to lung in multiple mouse metastatic tumor models. Nr4a1-deficient mice, which specifically lack PMo, showed increased lung metastasis in vivo. Transfer of Nr4a1-proficient PMo into Nr4a1-deficient mice prevented tumor invasion in the lung. PMo established early interactions with metastasizing tumor cells, scavenged tumor material from the lung vasculature, and promoted natural killer cell recruitment and activation. Thus, PMo contribute to cancer immunosurveillance and may be targets for cancer immunotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom